艾滋病专题 |
|
|
|
|
人类免疫缺陷病毒储存库评估测定技术研究进展 |
周琦惠, 朱彪 |
浙江大学医学院附属第一医院感染病中心 传染病诊治国家重点实验室 感染病诊治协同 创新中心, 浙江 杭州 310003 |
|
Research advances in evaluation and measurement techniques of latent human immunodeficiency virus reservoirs |
ZHOU Qihui, ZHU Biao |
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China |
[1] |
DAHL V, JOSEFSSON L, PALMER S. HIV reservoirs, latency, and reactivation: prospects for eradication[J]. Antiviral Res, 2010, 85(1): 286-294.
|
[2] |
LAIRD G M, EISELE E E, RABI S A, et al. Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay[J/OL]. PLoS Pathog, 2013, 9(5): e1003398.
|
[3] |
BRUNER K M, HOSMANE N N, SILICIANO R F. Towards an HIV-1 cure: measuring the latent reservoir[J]. Trends Microbiol, 2015, 23(4): 192-203.
|
[4] |
BAROUCH D H, DEEKS S G. Immunologic strategies for HIV-1 remission and eradication[J]. Science, 2014, 345(6193): 169-174.
|
[5] |
SHAN L, SILICIANO R F. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication[J]. Bioessays, 2013, 35(6): 544-552.
|
[6] |
LISZEWSKI M K, YU J J, O'DOHERTY U. Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR[J]. Methods, 2009, 47(4): 254-260.
|
[7] |
AGOSTO L M, LISZEWSKI M K, MEXAS A, et al. Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs[J]. Virology, 2011, 409(1):46-53.
|
[8] |
O'DOHERTY U, SWIGGARD W J, JEYAKUMAR D, et al. A sensitive, quantitative assay for human immunodeficiency virus type 1 integration[J]. J Virol, 2002, 76(21): 10942-10950.
|
[9] |
HAN Y, ROTOLO M W, YANG H C, et al. Experimental approaches to the study of HIV-1 latency[J]. Nat Rev Microbiol, 2007, 5(2): 95-106.
|
[10] |
BARTON K M, PALMER S E. How to define the latent reservoir:tools of the trade[J].Curr HIV/AIDS Rep, 2016, 13(2): 77-84.
|
[11] |
ARCHIN N M, SUNG J M, GARRIDO C, et al. Eradicating HIV-1 infection: seeking to clear a persistent pathogen[J]. Nat Rev Microbiol, 2014, 12(11): 750-764.
|
[12] |
PROCOPIO F A, FROMENTIN R, KULPA D A, et al. A novel assay to measure the magnitude of the inducible viral reservoir in HIV-infected individuals[J]. EBioMedicine, 2015, 2(8): 874-883.
|
[13] |
PASTERNAK A O, LUKASHOV V V, BERKHOUTB. Cell-associated HIV RNA: a dynamic biomarker of viral persistence[J]. Retrovirology, 2013, 10:41.
|
[14] |
ALIDJINOU E K, BOCKET L, HOBER D. Quantification of viral DNA during HIV-1 infection: a review of relevant clinical uses and laboratory methods[J]. Pathol Biol (Paris), 2015, 63(1):53-59.
|
[15] |
KISELINOVA M, SPIEGELAERE W D, BUZON M J, et al. Integrated and total HIV-1 DNA predict ex vivo viral outgrowth[J/OL]. PLoS Pathog, 2016, 12(3): e1005472.
|
[16] |
CHUN T W, CARRUTH L, FINZI D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection[J]. Nature, 1997, 387(6629): 183-188.
|
[17] |
TYAGI M, BUKRINSKY M. Human immunodeficiency virus (HIV) latency: the major hurdle in hiv eradication[J]. Mol Med, 2012, 18: 1096-1108.
|
[18] |
CHUN T W, MOIR S, FAUCI A S. HIV reservoirs as obstacles and opportunities for an HIV cure[J]. Nat Immunol, 2015, 16(6): 584-589.
|
[19] |
ROUZIOUX C, RICHMAN D. How to best measure HIV reservoirs?[J]. Curr Opin HIV AIDS, 2013, 8(3): 170-175.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|